Natalie Y.L. Ngoi

机构：Institut Gustave Roussy, Assistance Publique Hôpitaux de Marseille, Centre d’Immunologie de Marseille-Luminy, National University Hospital · ORCID：0000-0003-2071-0715

发表论文 151 篇 · 总被引 2026 次 · h-index 24

代表论文

• Synthetic lethal strategies for the development of cancer therapeutics (2024 · Nature Reviews Clinical Oncology · 被引 73)
• Uterine leiomyosarcoma (2025 · International Journal of Gynecological Cancer · 被引 14)
• Durvalumab versus Physician’s Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial (2025 · Clinical Cancer Research · 被引 11)
• Unveiling Commonalities: Exploring Shared Characteristics in Clear-Cell Carcinomas of the Gynecologic Tract (2024 · Clinical Cancer Research · 被引 10)
• Clearer Horizons: The latest advances in clear cell ovarian cancer treatment (2025 · Cancer Treatment Reviews · 被引 8)
• Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world (2024 · ESMO Open · 被引 7)